Market Cap

Knight Therapeutics Inc. Market Capitalization:

C$582.3 Million

CAD as of Jan. 1, 2024

US$439.6 Million

business Knight Therapeutics Inc. Company Profile

Knight Therapeutics Inc. Main Stock Listing

TSX: GUD

Market Capitalization History of Knight Therapeutics Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Knight Therapeutics Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 C$582.3 M -2.67%
Jan. 1, 2023 C$598.3 M -4.68%
Jan. 1, 2022 C$627.7 M 4.91%
Jan. 1, 2021 C$598.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Knight Therapeutics Inc. Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

Knight Therapeutics Inc. has the following listings and related stock indices.


Stock: TSX: GUD

Stock: FSX: 04K

Stock: OTC: KHTRF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.